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Abstract
Background: Parry-Romberg syndrome (PRS) is a rare disorder characterized by unilateral facial atrophy affecting
the skin, subcutaneous tissue, muscles, and sometimes extending to the osteocartilaginous structures. Ocular
involvement is relatively rare.
Case presentation: We present a case of a 23-year-old female caucasian patient with Parry Romberg syndrome and
extensive ocular involvement: enophthalmos, uveitis, iris atrophy. Ultrasound biomicroscopy (UBM) demonstrated
hypotrophy of the ciliary body. The ciliary body atrophy has been previously reported just once and can be an
explanation for the hypotony, frequently present in these patients.
Conclusions: Parry Romberg syndrome is a rare multidisciplinary disease. Our case presents a full spectrum of ocular
manifestations. The pathogenesis of hypotonia is discussed.
Background
Parry-Romberg syndrome (PRS) is a rare disorder char-
acterized by unilateral facial atrophy affecting the skin,
subcutaneous tissue, muscles, and sometimes extending
to the osteocartilaginous structures [1–4]. Ophthalmic
involvement is uncommon with the most frequent
finding being enophthalmos [5–11].
We present a case of PRS with enophthalmos, uveitis,
ciliary body hypotrophy and phacodonesis.
Case presentation
23 years old lady with 16 years history of Parry Romberg
syndrome was referred to our clinic. The family history was
positive for autoimmune diseases: her father was affected by
rheumatoid arthritis and her first degree aunt by cutaneous
psoriasis. No other cases of PRS were reported in the family.
She did not report previous trauma, but had a Varicella
Zoster virus (VZV) infection when she was 5 years old.
When 6 years old, she developed a dermal hyperpigmented
lesion in the left side of the neck. One year later she pre-
sented signs of left hemifacial atrophy. She progressively
developed atrophy of cutaneous and subcutaneous fat tissue
with maxillary-mandibular asimmetry and enophthalmos.
The nasal septum and the mouth were deviated (Fig. 1).
The disease progression stopped when she was 15 years old.
She then underwent two autologous fat injections which
reabsorbed after a few months. She didn’t undergo further
surgical interventions. The disease is presently stable (Fig. 2).
She complained migraine, but no other neurological
symptoms. Serological tests were positive for anti-
streptolysin O titre (369 U/ml; range 0-250 U/ml),
rheumatoid factor (101 U/ml; range 0-40 U/ml), anti-
bodies against nucleic (>1:640; range < 1:160) and against
double strain DNA (42 U/ml; range < 30 - >50). The rheu-
matologic examination was negative. TSH was mildly ele-
vated (4.27 UI/ml; range 0.2-4 UI/ml), but T3 and T4
were still in the normal range (T3:3.29 pg/ml; range 2.35-
4.55 pg/ml and T4: 13.12 pg/ml; range 6.95-18.20 pg/ml),
suggesting a subclinical hypothyroidism.
The ocular involvement started simultaneous to the
development of facial atrophy. She first reported intense
photofobia and she presented with multiple episodes of
left iridocyclitis in the following years. She was diag-
nosed with Fuchs heterochromic iridocyclitis.
She presented to our Clinic with left enophthalmos and
pseudoptosis. Her best corrected visual acuity was 20/20
in the right eye and 20/60 in the left eye. The anterior seg-
ment examination showed bilateral non-pigmented endo-
thelial deposits (Fig. 3a and b), but no flare. The left iris
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was atrophic with partial aniridia, the pupil was non re-
active to light (Fig. 4). The anterior chamber depth was
reduced in periphery. Gonioscopy showed a narrow
angle grade 1‐2 (Shaffer) (Fig. 5a and b) and ultrasound
biomicroscopy (UBM) demonstrated a narrow angle at
3,6 and 12 o’clock and a closed angle at 9 o’clock. Un-
expectedly during this exam, the ciliary body was atro-
phic (Fig. 6a,b,c,d). The right eye UBM reported a
dystrophic ciliary body (Fig. 6e).
The lens showed phacodonesis. The intraocular pres-
sure (IOP) measured with Goldmann applanation tonom-
etry was 12 mmHg in the right eye and 10 mmHg in the
left eye. Fundus examination was normal in both eyes.
Conclusions
Parry-Romberg syndrome (PRS) is a rare disorder char-
acterized by atrophy of cutaneous, subcutaneous fatty
tissue, muscle tissue and rarely bone structures. It is
Fig. 1 3D CT. 3D CT images show the normal anatomical right and deviated nasal septum, tilt in the occlusal table, hypoplastic zygomatic
complex and orbital wall on left side
Fig. 2 Patient image. Picture taken during our ophtalmic evaluation,
showing the actual situation of the patient after two autologous
fat injection
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more common in women, it usually involves one side of
the face, the ipsilateral involvement of the body is rare and
20 % of cases are bilateral [9]. PRS usually begins in the first
decade of life [1–3, 12], although some cases with a late on-
set have been described [12], and is slowly progressive over
two to twenty years and then stabilizes [1, 2, 13–16]. Our
patient shows a typical onset in childhood and the progres-
sion was slow in the following ten years.
PRS etiology in still unknown: traumatic, genetic, im-
mune mediated processes, hormonal disregulation, infec-
tion (Herpes and Borrelia burgdorferi mostly involved
[17–19]) and sympathetic dysfunction have been pro-
posed. In our case we found an history of familial genetic
predisposition to develop autoimmune disease, a sero-
logical assessment demonstrated a potential immune and
hormonal disregulation, and a positive history of Varicella
Zoster Virus infection preceding the PRS.
As referred in literature, an early sign of PRS is a
frontal hypo or hyperpigmented skin lesion known as
“frontal linear scleroderma en coupe de sabre”, a local-
ised form of sclerodermia. In our case the only sign
preceding the developement of the atrophy was a hy-
perpigmented neck lesion. Frontal linear sclerodermia
(LSCS) and PRS have the same starting age, disease
progression, ocular and neurological involvement and
predominantly affect women. The prevalence of LSCS
in conjunction with PRS is uncertain, but has been re-
ported to range from 36.6 % to 53.6 % [20]. For this
reason it has been suggested that PRS is a form of
scleroderma, although some Authors believe that they
are separate entities [20–23].
PRS often coexists with neurological, cardiac, ophtal-
mological, rheumatological, endocrine, maxillo-facial
and orthodontal disorders [7]. Neurological involvement
is the most common association [24, 25] including
migraine, hemiplegia, brain atrophy, and intracranial
vascular anomalies. For this reasons some Authors con-
sider the PRS as a neuro-cutaneous syndrome [24, 25].
Fig. 3 Slit lamp anterior segment photography. Anterior segment photos show bilateral non pigmented endothelial deposits (a right eye, b left
eye); iris atrophy, partial aniridia and fully dilated pupil on left eye
Fig. 4 Aniridia. Picture showing differences between two eyes in terms of aniridia and pupil size
Fea et al. BMC Ophthalmology  (2015) 15:119 Page 3 of 6
Fig. 5 Gonioscopy. Gonioscopy images showing a closed angle in superior (a) and inferior (b) sectors
Fig. 6 UBM images of left eyes taken at 3-6-9-12 o’clock respectively (a, b, c, d) showing a narrow angle at 3-6 and 12 o’clock and a closed angle
at 9 o’clock. The ciliary body is hypotrophic (coarser white arrows). UBM image of right eye (8e) showing a dystrophic ciliary body (thinner
white arrows)
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In our case migraine was the only neurological symptom
presented by the patient.
Several ophthalmologic associations have been previ-
ously described, affecting 10-30 % of patients, the most
common being enophthalmos, eyelid atrophy, uveitis,
retinal vasculitis, oculo-motor defects and glaucoma.
Other findings are presented in Table 1.
Our patient had an extensive ophthalmologic in-
volvement: enophthalmos, pseudoptosis, uveitis, iris at-
rophy and partial aniridia, narrow angle, phacodonesis
and ciliary body hypotrophy. Phacodonesis has never
been reported before and ciliary body atrophy has
recently been reported by Ashwini Kini et al. (2015)
[26].
The ciliary body hypotrophy should have led to ocular
hypotony, but the IOP was similar in both eyes. The
presence of the narrow angle and thus a reduction of
outflow may compensate for the decrease of inflow.
Alternatively, the ciliary body, although atrophic, might
be still functional and its production of acqueous humor
sufficient to prevent hypotonia.
Previous Authors reported occurrence of hypotony or
glaucoma in patients with the Parry Romberg Syndrome.
Hypotony is generally considered as consequent to an
edema of the ciliary body due to uveitis [27]. The occur-
rence of glaucoma has been considered secondary to
uveitis or angle closure [28].
Our findings of ciliary body hypotrophy was occa-
sional. We were evaluating the chamber angle with
UBM and we came across this novel finding.
UBM examination is in general seldom used in the
ophthalmic practice and ciliary hypotrophy might be
more frequent than expected in this Syndrome, which
affects mesodermic and ectodermic tissues.
We suggest that UBM examination should be further
used in anterior segment malformations associated with
the Parry Romberg syndrome.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this Journal.
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